Riley said that they need to raise more money but they are also in talks for one or both drugs in partnerships. He stated again they want to raise money in a non-diluted way. So maybe they will get that partner to pay our way.
Nokia would of been a great investment until they want and bought that Albatross ALU company. I sold in fall for around $7 but should of sold in the spring when NOK was $8+, when there were rumors circulating about an ALU buyout. I still doubled my money but I believe NOK if they would of went aggressive with share buybacks and growing internally would be a double digit stock now.
Still it was a great investment for me, it made me money.
Maybe NOK will be able to fix ALU but not sure if they can. For a company that had so many issues to get back on its feet it was wrong buying another firm that could never make a profit after Alcatel had merged with Lucent.
I actually prefer to have a bigger pharma as a partner. If one of these drugs makes it you need the connections to sell the drug as well. It can hurt some upside but at the same time higher revenues over a longer period tends to make it better for a small cap to partner up. Now you could make a lot more if you got approval then had multiple companies suddenly bidding you up.